Table 1.
Summary of patient characteristics and histopathological response to chemotherapy.
| Mean ± Standard Deviation/Percentage | |
|---|---|
| Age | 49 ± 11 years |
| Initial Tumour Size | 5.9 ± 2.8 cm |
| Histology | |
| Invasive Ductal Carcinoma: 95% | |
| Invasive Lobular Carcinoma: 5% | |
| Tumour Grade | |
| Grade I: 10% | |
| Grade II: 63% | |
| Grade III: 27% | |
| Molecular Features | |
| ER/PR+: 63% | |
| ER/PR+ & HER2−: 40% | |
| HER2+: 32% | |
| ER− & PR− & HER2+: 9% | |
| ER− & PR− & HER2−: 28% | |
| Residual Tumour Size | 3.1 ± 4.0 cm |
| Miller-Payne Score | |
| MP 1: 7% | |
| MP 2: 12% | |
| MP 3: 41% | |
| MP 4: 15% | |
| MP 5: 23% | |
| Response | |
| Responder: 81% | |
| Non-responder: 19% | |